ArticleGynecologic oncology reports2022

Re-treatment with PARPi in patients with recurrent epithelial ovarian cancer: A single institutional experience.

Malak Moubarak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.